Innovative Medicines Provide Greater Value to Patients and

New report finds critical flaws in drug pricing math used to deny patient care Traditional cost-effectiveness math omits quantifiable values recommended...

Related Keywords

United States ,Washington ,Colorado ,Americans ,Peter Rubin ,Darius Lakdawalla ,Neal Masia ,Institute For Clinical ,Economic Review ,Executive Director ,Chief Scientific Officer ,Cost Effectiveness Math Better ,Inflation Reduction Act ,State Prescription Drug Affordability Board ,No Patient Left Behind ,